top of page

News & Updates

Filter by:

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

News & Updates

Aug 7, 2023

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

News & Updates

Jul 24, 2023

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

News & Updates

May 26, 2023

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

News & Updates

May 10, 2023

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence secures US Medicare approval for its cancer tests

News & Updates

Mar 20, 2023

Lucence secures US Medicare approval for its cancer tests

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

News & Updates

Feb 22, 2023

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

News & Updates

Oct 23, 2022

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

News & Updates

Oct 18, 2022

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

News & Updates

Sep 26, 2022

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

1

/

5

bottom of page